Previous 10 | Next 10 |
2024-05-25 08:41:46 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Novo Nordisk once weekly insulin fails to get thu...
2024-05-25 07:00:00 ET Summary Buying stocks at record highs doesn't necessarily mean lower returns, and can actually lead to higher returns in the short term. Valuations matter, but the metric used to evaluate them is important. Cash-adjusted valuations provide a more accurate pi...
2024-05-25 06:47:00 ET What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run. We asked three Motley Fool contributors to look among recently high-flying stocks for those that they believe could...
2024-05-24 16:16:00 ET More on Novo Nordisk Novo weight loss therapy cuts mortality risk in kidney disease SA Asks: Is Eli Lilly or Novo Nordisk a better investment? The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings C...
2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...
2024-05-24 10:40:44 ET More on Zealand Pharma Zealand Pharma A/S (ZLDPF) Q1 2024 Earnings Call Transcript Zealand Pharma: Survodutide Has Potential Beyond Obesity Treatment Zealand Pharma A/S (ZEAL) Q4 2023 Earnings Call Transcript Historical earnings data fo...
2024-05-24 09:17:15 ET Summary Medifast's financial performance is deteriorating rapidly due to the emergence of drug-weight loss competitors. The company reported a significant decline in revenue and earnings in Q1 2023. Medifast is laying off employees and may need to furthe...
2024-05-24 07:06:38 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript SA Asks: Is Eli Lilly or Novo Nordisk a better in...
2024-05-23 14:07:59 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic FDA reviewers voice concerns o...
2024-05-22 13:32:00 ET Summary Australia to ban compounded versions of Novo Nordisk's semaglutide and Eli Lilly's tirzepatide due to safety concerns. Existing home sales dipped 1.89% in April to 4.14 million. All eyes on Nvidia earnings but BofA points to another stock that de...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...
2024-07-14 05:20:00 ET Two pharma juggernauts, Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) , are picking up speed in their preparations for an epic battle to control the market for weight loss drugs. The prize for the victor will be a larger market share of what may b...